Computational and Structural Biotechnology JournalBioinformaticsPeer-reviewed journal article
Machine learning driven acceleration of biopharmaceutical formulation development using Excipient Prediction Software (ExPreSo)
Estefania Vidal-HenriqueziD, Thomas M. Holder, Nicholas Franciss LeeiD, Cornelius Pompe, Mark G. TeeseiD
Abstract
Formulation development of protein biopharmaceuticals has become increasingly challenging due to new modalities and higher target drug substance concentrations. The limited amount of drug substance available during development, coupled with extensive analytical requirements, restrict the number of excipients that can be empirically screened. There is a strong need for in silico tools to optimize excipient pre-selection before wet lab experiments. Here, we introduce Excipient Prediction Software (ExPreSo), a supervised machine learning algorithm that suggests excipients based on the properties of the protein drug substance and target product profile. ExPreSo was trained on a dataset comprising 335 regulatory-approved peptide and protein drug products. Predictive features included protein structural properties, protein language model embeddings, and drug product characteristics. ExPreSo showed good performance for the nine most prevalent excipients in biopharmaceutical formulations and minimal overfitting. A fast variant of ExPreSo using only sequence-based input features showed similar prediction power to slower models that relied on molecular modeling. Notably, an ExPreSo variant using only protein-based input features also showed good performance, indicating resilience to the influence of platform formulations. To our knowledge, this is the first machine learning algorithm to suggest biopharmaceutical excipients based on the dataset of regulatory-approved drug products. Overall, ExPreSo shows great potential to reduce the time, costs, and risks associated with excipient screening during formulation development. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=77 SRC="FIGDIR/small/637685v3_ufig1.gif" ALT="Figure 1"> View larger version (29K): org.highwire.dtl.DTLVardef@2e3e5corg.highwire.dtl.DTLVardef@342aorg.highwire.dtl.DTLVardef@160df8forg.highwire.dtl.DTLVardef@f547d8_HPS_FORMAT_FIGEXP M_FIG C_FIG
- assay: protein sequence
- research focus: drug response / drug discovery
- approach: machine learning (classical)
- Citations
- 9
- FWCI
- 2.72
- Field percentile
- top 9%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A computational procedure for predicting excipient effects on protein-protein affinities
G. L. Dignon, K. A. Dill·bioRxiv·Dec 22, 2023
- Predicting the Activities of Drug Excipients on Biological Targets using One-Shot Learning
- Defining Structure-Function Relationships of Amphiphilic Excipients Enables Rational Design of Ultra-Stable Biopharmaceuticals
Alexander N. Prossnitz, Leslee T. Nguyen, … Eric Andrew Appel·Advanced SciencePeer-reviewed·Jan 7, 2025
- Molecularly specific solubilization of therapeutic antibodies
Zexiang Han, Nadia A. Erkamp, … Tuomas P. J. Knowles·bioRxiv·Jan 30, 2026
- Accelerating Antibody Development: Sequence and Structure-Based Models for Predicting Developability Properties through Size Exclusion Chromatography
A N M Nafiz Abeer, Mehdi Boroumand, … Maryam Pouryahya·bioRxiv·Feb 2, 2025
- SolXplain: An Explainable Sequence-Based Protein Solubility Predictor
Raghvendra Mall·bioRxiv·May 27, 2019